These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21509478)

  • 41. A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.
    Hawkins J; Kodali S; Matsuka YV; McNeil LK; Mininni T; Scully IL; Vernachio JH; Severina E; Girgenti D; Jansen KU; Anderson AS; Donald RG
    Clin Vaccine Immunol; 2012 Oct; 19(10):1641-50. PubMed ID: 22896688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role and plasticity of Th1 and Th17 responses in immunity to
    Ferraro A; Buonocore SM; Auquier P; Nicolas I; Wallemacq H; Boutriau D; van der Most RG
    Hum Vaccin Immunother; 2019; 15(12):2980-2992. PubMed ID: 31149870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
    Skurnik D; Kropec A; Roux D; Theilacker C; Huebner J; Pier GB
    Clin Infect Dis; 2012 Nov; 55(9):1188-97. PubMed ID: 22806596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of the humoral immunological response after vaccination with a Staphylococcus aureus biofilm-embedded bacterin in dairy cows: possible role of the exopolysaccharide specific antibody production in the protection from Staphylococcus aureus induced mastitis.
    Prenafeta A; March R; Foix A; Casals I; Costa L
    Vet Immunol Immunopathol; 2010 Apr; 134(3-4):208-17. PubMed ID: 19836084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Staphylococcus aureus and Host Immunity in Recurrent Furunculosis.
    Nowicka D; Grywalska E
    Dermatology; 2019; 235(4):295-305. PubMed ID: 30995649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
    PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global antibody response to Staphylococcus aureus live-cell vaccination.
    Selle M; Hertlein T; Oesterreich B; Klemm T; Kloppot P; Müller E; Ehricht R; Stentzel S; Bröker BM; Engelmann S; Ohlsen K
    Sci Rep; 2016 Apr; 6():24754. PubMed ID: 27103319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.
    Creech CB; Frenck RW; Sheldon EA; Seiden DJ; Kankam MK; Zito ET; Girgenti D; Severs JM; Immermann FW; McNeil LK; Cooper D; Jansen KU; Gruber W; Eiden J; Anderson AS; Baber J
    Vaccine; 2017 Jan; 35(2):385-394. PubMed ID: 27866765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting the R domain of coagulase by active vaccination protects mice against lethal Staphylococcus aureus infection.
    Qian M; Zhao T; Li R; Yang Q; Yu R; Yin Y; Zai X; Li Y; Zhang J; Xu J; Chen W
    Microbes Infect; 2019; 21(3-4):163-169. PubMed ID: 30447395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.
    Liu Q; Du X; Hong X; Li T; Zheng B; He L; Wang Y; Otto M; Li M
    Infect Immun; 2015 May; 83(5):2168-74. PubMed ID: 25776748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
    Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD
    Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in humoral immune response between patients with or without nasal carriage of Staphylococcus aureus.
    Ghasemzadeh-Moghaddam H; van Wamel W; van Belkum A; Hamat RA; Neela VK
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):451-458. PubMed ID: 27815779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.
    Chen WH; Pasetti MF; Adhikari RP; Baughman H; Douglas R; El-Khorazaty J; Greenberg N; Holtsberg FW; Liao GC; Reymann MK; Wang X; Warfield KL; Aman MJ
    Clin Vaccine Immunol; 2016 Dec; 23(12):918-925. PubMed ID: 27707765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein.
    Therrien R; Lacasse P; Grondin G; Talbot BG
    Vaccine; 2007 Jun; 25(27):5053-61. PubMed ID: 17532546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological responses and evaluation of the protection in dairy cows vaccinated with staphylococcal surface proteins.
    Merrill C; Ensermu DB; Abdi RD; Gillespie BE; Vaughn J; Headrick SI; Hash K; Walker TB; Stone E; Kerro Dego O
    Vet Immunol Immunopathol; 2019 Aug; 214():109890. PubMed ID: 31378218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. I. Challenge trials.
    Leitner G; Lubashevsky E; Glickman A; Winkler M; Saran A; Trainin Z
    Vet Immunol Immunopathol; 2003 May; 93(1-2):31-8. PubMed ID: 12753773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two Vaccines for
    Dupont CD; Scully IL; Zimnisky RM; Monian B; Rossitto CP; O'Connell EB; Jansen KU; Anderson AS; Love JC
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135219
    [No Abstract]   [Full Text] [Related]  

  • 58. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
    Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
    Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine.
    Marshall HS; Baber J; Richmond P; Nissen M; Shakib S; Kreiswirth BN; Zito ET; Severs J; Eiden J; Gruber W; Jansen KU; Jones CH; Anderson AS
    J Infect; 2019 Dec; 79(6):582-592. PubMed ID: 31585191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
    Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
    mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.